iMDx develops molecular diagnostic tests for transplanted organ rejection and sells them to hospitals, transplant centers and labs. It last closed at $1.97 on Nov 20, up 18.67% on the day. The next earnings report for IMDX is expected around Thu, Mar 25, 2027, after the close. For the quarter ended Sep 2026, IMDX reported EPS of -$0.10 on revenue of $559,000, with revenue up 115.0% from a year ago. Over its last 8 reports the stock moved an average of 9.4% the session after earnings. Over the last 12 months IMDX insiders bought $11.7M of stock on the open market and sold $0, according to SEC Form 4 filings.
AI Auto Pilots
Is IMDX in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold IMDX.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on IMDXStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
IMDX · as of the Nov 20 close · updated each morning
Downtrend, nearing oversold
The stock is 25% below its 20 day and 55% below its 50 day average. It is 124% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 35), near oversold. The nearest support is the Pivot at $1.87, and the nearest resistance the Pivot R1 at $2.11.
Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityHigh, 14.8%/day
Key levels
$7.5152 week high+281.2%
$4.41200 day average+123.9%
$3.81100 day average+93.4%
$3.25Swing high (Oct 27)+65.0%
$3.0550 day average+54.8%
$2.4720 day average+25.4%
$2.11Pivot R1+7.1%
$1.97Last close
$1.87Pivot−5.1%
$1.72Pivot S1−12.7%
$1.5052 week low−23.9%
Indicators
RSI (14)
34.61
Weak, oversold below 30
Neutral
MACD
-0.38
Below its signal line
Bearish
Stochastic
14.8
Near the bottom of its range
Oversold
ADX (14)
36.2
Trending down
Williams %R
-71.0
Oversold below −80, overbought above −20
Neutral
CCI (20)
-102.0
Oversold below −100, overbought above 100
Oversold
Rate of change
−20.9%
Change over 10 sessions
Bearish
ATR (14)
$0.29
Typical daily range, 14.8% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Falling, oversold
Short trendBearish
Long trendNot enough history
MomentumWeak
StretchOversold
VolatilityHigh, 39.3%/day
Key levels
$7.5152 week high+281.2%
$4.41200 day average+123.9%
$3.81100 day average+93.4%
$3.25Swing high (Oct 27)+65.0%
$3.0550 day average+54.8%
$2.4720 day average+25.4%
$2.11Pivot R1+7.1%
$1.97Last close
$1.87Pivot−5.1%
$1.72Pivot S1−12.7%
$1.5052 week low−23.9%
Indicators
RSI (14)
25.64
Oversold below 30
Oversold
MACD
-0.70
Below its signal line
Bearish
Stochastic
7.6
Near the bottom of its range
Oversold
ADX (14)
29.3
Trending down
Williams %R
-84.5
Oversold below −80, overbought above −20
Oversold
CCI (20)
-167.8
Oversold below −100, overbought above 100
Oversold
Rate of change
−53.1%
Change over 10 sessions
Bearish
ATR (14)
$0.77
Typical daily range, 39.3% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200–
What happened before, for IMDX
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how IMDX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow IMDX usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for IMDXHow many large options trades hit IMDX, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in IMDX in the last 90 days.
From SEC Form 4 filings by IMDX's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether IMDX is in one of them and how their past IMDX trades turned out.
iMDx is a diagnostics company based in Nashville, Tennessee. Its main focus is molecular tests that help monitor whether a transplanted organ is being rejected, sold under the GraftAssure name. The test kits are meant for hospitals, transplant centers and labs to run in their own facilities, and research kits are offered to research laboratories. The company also runs a clinical lab in Franklin, Tennessee, and provides assay development and testing services to life sciences and biotechnology companies.